Greene Tweed Launches Fusion™ 665, an Ultra-Low-Temperature FKM
Greene Tweed’s Fusion™ FKM 665, a new generation, ultra-low-temperature and chemical-resistant elastomer, was specifically formulated to meet and exceed the requirements of Aerospace Material Specification (AMS) 7379 and AMS-P-83461.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190205005898/en/
With a temperature range of -70°F to 450°F (-57°C to 232°C), Fusion™ 665 achieves outstanding low-temperature performance without compromising high-temperature performance.
“Prior to Greene Tweed’s Fusion™ 665, elastomer material composition resulted in trade-offs,” said Wally Hajduczek, Sealing Systems Product Manager for Aerospace, Defense, and Life Sciences. “Achieving optimal low-temp performance meant sacrificing high-temperature operating range, chemical compatibility, or dynamic sealing performance. Fusion™ 665 was developed to overcome existing limitations of comparable materials, such as NBR, FKM, or FVMQ (Fluorosilicone).”
To learn more about Fusion™ 665, click here: https://hubs.ly/H0gdRfy0 .
About Greene Tweed
Greene Tweed is a leading global manufacturer of high-performance thermoplastics, composites, seals, and engineered components. Combining more than 150 years of technical expertise and commercial knowledge in a variety of markets, Greene Tweed collaborates with customers to develop engineered solutions that meet challenging performance requirements and reduce total cost of ownership.
Greene Tweed products are sold and distributed worldwide. For additional information, call +1.215.256.9521, or visit our website at http://www.gtweed.com .
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NJ-CELGENE19.7.2019 20:01:04 CEST | Press release
FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease
JANSSEN19.7.2019 15:07:11 CEST | Press release
Abiraterone Acetate Included in World Health Organisation’s Essential Medicines List for the Treatment of Metastatic Castration-Resistant Prostate Cancer
CA-GILEAD-SCIENCES19.7.2019 14:32:09 CEST | Press release
Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis
SCHLUMBERGER-LIMITED19.7.2019 13:02:04 CEST | Press release
Schlumberger Announces Second-Quarter 2019 Results
TX-SCHLUMBERGER-LIMITED19.7.2019 12:48:04 CEST | Press release
Schlumberger Appoints Olivier Le Peuch as CEO
WA-FLUKE-CORPORATION19.7.2019 12:02:10 CEST | Press release
Fluke Corporation Acquires Industrial Reliability Leader PRÜFTECHNIK
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom